Mayer EL - Search Results

1

Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer.

Lee GE, Rosenberg SM, Mayer EL, Borges V, Meyer ME, Schapira L, Come SE, Partridge AH. Lee GE, et al. Among authors: mayer el. Breast J. 2019 Nov;25(6):1104-1110. doi: 10.1111/tbj.13431. Epub 2019 Jul 18. Breast J. 2019. PMID: 31318125

2

Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons.

Burstein HJ, Mayer E, Patridge AH, O'Kane H, Litsas G, Come SE, Hudis CA, Goldstein DF, Muss HB, Winter EP, Garber JE. Burstein HJ, et al. Clin Breast Cancer. 2006 Jun;7(2):158-61. doi: 10.3816/cbc.2006.n.026. Clin Breast Cancer. 2006. PMID: 16800976

3

Chemotherapy for metastatic breast cancer.

Mayer EL, Burstein HJ. Mayer EL, et al. Hematol Oncol Clin North Am. 2007 Apr;21(2):257-72. doi: 10.1016/j.hoc.2007.03.001. Hematol Oncol Clin North Am. 2007. PMID: 17512448 Review.

4

Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer.

Mayer EL, Carey LA, Burstein HJ. Mayer EL, et al. Breast Cancer Res. 2007;9(5):110. doi: 10.1186/bcr1755. Breast Cancer Res. 2007. PMID: 17888189 Free PMC article.

5

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.

Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A. Partridge AH, et al. J Clin Oncol. 2008 Feb 1;26(4):556-62. doi: 10.1200/JCO.2007.11.5451. Epub 2008 Jan 7. J Clin Oncol. 2008. PMID: 18180462

6

Patient adherence and persistence with oral anticancer treatment.

Ruddy K, Mayer E, Partridge A. Ruddy K, et al. CA Cancer J Clin. 2009 Jan-Feb;59(1):56-66. doi: 10.3322/caac.20004. CA Cancer J Clin. 2009. PMID: 19147869 Free article. Review.

7

Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.

Mayer EL, Partridge AH, Harris LN, Gelman RS, Schumer ST, Burstein HJ, Winer EP. Mayer EL, et al. Breast Cancer Res Treat. 2009 Oct;117(3):615-23. doi: 10.1007/s10549-009-0366-5. Epub 2009 Mar 18. Breast Cancer Res Treat. 2009. PMID: 19294501 Free PMC article. Clinical Trial.

8

Breast cancer survivors' perceptions of survivorship care options.

Mayer EL, Gropper AB, Neville BA, Partridge AH, Cameron DB, Winer EP, Earle CC. Mayer EL, et al. J Clin Oncol. 2012 Jan 10;30(2):158-63. doi: 10.1200/JCO.2011.36.9264. Epub 2011 Dec 12. J Clin Oncol. 2012. PMID: 22162585 Free PMC article.

9

Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics.

Mayer EL, Isakoff SJ, Klement G, Downing SR, Chen WY, Hannagan K, Gelman R, Winer EP, Burstein HJ. Mayer EL, et al. Breast Cancer Res Treat. 2012 Nov;136(1):169-78. doi: 10.1007/s10549-012-2256-5. Epub 2012 Sep 23. Breast Cancer Res Treat. 2012. PMID: 23001754 Free PMC article. Clinical Trial.

10

A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer.

Lin NU, Seah DS, Gelman R, Desantis S, Mayer EL, Isakoff S, Dipiro P, Krop IE, Come SE, Weckstein D, Winer EP, Burstein HJ. Lin NU, et al. Among authors: mayer el. Breast Cancer Res Treat. 2013 Jun;139(2):403-10. doi: 10.1007/s10549-013-2551-9. Epub 2013 May 5. Breast Cancer Res Treat. 2013. PMID: 23645007 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page